SCHEMBL5833295

SCHEMBL5833295

[CH2]C1C2CCC1NC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1827359 0.78
SCHEMBL12289687 0.78
SCHEMBL12223046 0.78
SCHEMBL4966905 0.69
SCHEMBL25910764 0.68
SCHEMBL4240469 0.67
SCHEMBL24584387 0.67
SCHEMBL13650772 0.67
SCHEMBL18968869 0.67
SCHEMBL6982703 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1317430-B1 (2-AZABICYCLO [2.2.1]HEPT-7-YL)METHANOL DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS MERCK PATENT GMBH (DE) 2005-05-18 EP claimed
US-20040039045-A1 (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists MERCK PATENT GMBH (DE) 2004-02-26 US claimed
US-7008955-B2 (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists MERCK PATENT GMBH (DE) 2006-03-07 US disclosed
US-20040110788-A1 Nicotinic acetylcholine receptor ligands MERCK PATENT GMBH (DE) 2004-06-10 US disclosed
US-20040039045-A1 (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists MERCK PATENT GMBH (DE) 2004-02-26 US disclosed
EP-1379502-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS MERCK PATENT GmbH (DE) 2004-01-14 EP disclosed
WO-2002083640-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS MERCK PATENT GMBH (DE) 2002-10-24 WO disclosed